Chiral self assembled monolayers as resolving auxiliaries in the crystallization of valine
Article first published online: 8 JUN 2010
DOI: 10.1002/jps.22237
Copyright © 2010 Wiley-Liss, Inc.
Issue
1520-6017/asset/cover.gif?v=1&s=e589ccf35fd012c675e943835781318cb8666bed)
Journal of Pharmaceutical Sciences
Special Issue: Dedicated to Stephen R. Byrn
Volume 99, Issue 9, pages 3931–3940, September 2010
Total views since August 2010: 352
Additional Information
How to Cite
Singh, A. and Myerson, A. S. (2010), Chiral self assembled monolayers as resolving auxiliaries in the crystallization of valine. J. Pharm. Sci., 99: 3931–3940. doi: 10.1002/jps.22237
Publication History
- Issue published online: 22 JUL 2010
- Article first published online: 8 JUN 2010
- Manuscript Accepted: 26 APR 2010
- Manuscript Revised: 19 MAR 2010
- Manuscript Received: 16 JAN 2010
Keywords:
- chirality;
- crystallization;
- separation science;
- crystal engineering;
- crystal structure
Abstract
Chiral drugs are a subgroup of drug substances that contain one or more chiral centers. For reasons of safety and efficacy, the pure enantiomer is usually preferred over the racemate in many marketed dosage forms. Thus, resolution of racemic mixtures is an active area of research. In this work, chiral self assembled monolayers (SAMs) on gold were employed as resolving auxiliaries in the crystallization of the amino acid valine. Results showed the ability to obtain one enantiomer in excess on the crystals grown on the chiral SAMs when starting with racemic solutions. The enantiomer obtained in excess was the one having opposite chirality to the monolayer being used. In addition, it was possible to obtain crystals of the pure enantiomer when starting with a solution having an enantiomeric excess value of 50%. Control experiments carried out without chiral SAMs showed that at equilibrium, mixtures of the pure enantiomer and racemic compound were obtained under these conditions. The enantiomer obtained on the chiral SAMs was the one that was initially present in excess regardless of the chirality of the monolayer being used. © 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:3931–3940, 2010

1520-6017/asset/JPS_left.gif?v=1&s=becd26fac43b87042ad04af68bbe20d6a12e64fc)
1520-6017/asset/olbannerright.jpg?v=1&s=254f44b422de0f476861bd1056a1789033e2171c)